Tag: MilliporeSigma
Trial of High Efficiency TFF Capsule Prototype for ADC Purification
Antibody-drug conjugates (ADCs) are an emerging class of highly targeted cancer therapies in which a monoclonal antibody is chemically conjugated to a cytotoxic drug...
MilliporeSigma Introduces Integrated ADC Services to Reduce Complexity and Accelerate Time...
During the 7th World ADC Summit in Berlin, Germany, held February 20 - 22, 2017, MilliporeSigma announced that the company will now offer complete...